Dr. Amol Ubale

Sr. Consultant & Head of Department – M.D. Radiation Oncology

Dr. Amol Ubale is Senior most & dynamic Radiation Oncologist in Marathwada Region to Practice Precision and most advanced Radiation treatment since 2015. He completed his graduation from Government Medical College and Hospital, Aurangabad. He has completed his MD from Prestigious & One of the Oldest Cancer Institute in India – JK Cancer Institute, Kanpur. He has worked with Holy Spirit Cancer Centre, Holy Spirit Hospital, Andheri (E), Mumbai. He has experience of working as an Assistant Professor in Marathwada Regional Cancer Centre, Government Medical College, Aurangabad, Maharashtra.

Work Experience

2009 – 2012 - J.K Cancer Institute Kanpur
2012-2013 - Government Cancer Hospital
2013 – 2015 - Holy Spirit Cancer Centre Andheri, Mumbai.
2015 till date - As a Senior Consultant & Head of Department , Radiation Oncology, Dhoot Hospital, Aurangabad.

Education & Fellowship

M.B.B.S Completed From Government Medical College and Hospital, Aurangabad
M. D Completed from JK Cancer Institute, GSVM Medical College Kanpur
Training Interstitial Brachytherapy at Tata Memorial Hospital, Mumbai.
He Received Best Radiation Oncologist in Maharashtra Award by Times Groups in New Delhi in 2017.

Professional Membership

Maharashtra Medical Council.
AROI Life Member
ICON Life Member
AROI Maharashtra Chapter Member
Indian Brachytherapy Society Life Member
ESTRO ( European Society of Radiation Oncology)
eLORA Member

Areas of Expertise

Specializes in Precision Radiation treatment with RapidArc/VMAT, IMRT, IGRT and 3DCRT technique. Treated >5000 patients with EBRT till date.
Well versed with all kind of Brachytherapy Procedures . Done 2000+ Brachytherapy Procedures till date.
Rich Experience of treating more than 200 patients of Reirradiation of oral cavity malignancies, oropharyngeal cancers, laryngeal cancers, glioblastoma multiforme, diffuse intrinsic pontine glioma to name a few.
Special interest in Head and Neck Cancers, Gyneacological Cancers, Brain tumors, GI Malignancies
Successfully Treated > 500 Pediatric Cancer Patients